Neuroimaging findings
| Imaging Findings | No. | % | Imaging Findings | No. | % |
|---|---|---|---|---|---|
| White matter abnormalities | 16/16 | 100 | Atrophy | 15/16 | 94 |
| Symmetry | Atrophy predominance | ||||
| Symmetric | 10/16 | 63 | Frontal | 6/15 | 40 |
| Asymmetric | 6/16 | 37 | Frontoparietal | 8/15 | 53 |
| Confluence of lesions | Parietal | 1/15 | 7 | ||
| Confluent | 10/16 | 63 | Corpus callosum involvement | ||
| Patchy | 6/16 | 37 | Hyperintensities | 13/16 | 81 |
| White matter abnormalities predominance | Atrophy | 14/16 | 88 | ||
| Frontal | 13/16 | 81 | Corticospinal tract Deep gray matter nuclei | 10/16 2/16 | 63 13 |
| Frontoparietal | 3/16 | 19 | External capsule | 7/16 | 44 |
| Lobar distribution | Posterior fossa | 6/16 | 37 | ||
| Frontal | 16/16 | 100 | Enlarged perivascular spaces | 4/16 | 25 |
| Parietal | 16/16 | 100 | Diffusion-weighted imaging | ||
| Temporal | 11/16 | 69 | Hyperintensities | 6/8 | 75 |
| Occipital | 8/16 | 50 | Restricted ADC | 4/6 | 67 |
| U-fiber involvement | 8/16 | 50 | Calcifications | ||
| White matter rarefaction | 0/16 | 0 | T2* | 0/8 | 0 |
| CT | 4/6 | 67 | |||
| Gadolinium enhancement | 0/6 | 0 | |||
| Cavum septum pellucidum | 8/16 | 50 |